<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[c-08 Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/c-08.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to c-08]]></description>
	<s:counts start="0" returned="1" found="1" />
	<language>en-us</language>
	<item>
		<title><![CDATA[As Roche Looks on, Genentech's Big Avastin Study Attracts Critics]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000182/as-roche-looks-on-genentechs-big-avastin-study-attracts-critics/]]></link>
		<description><![CDATA[A handful of scientists are skeptical that Genentechâ€™s C-08 trial of its Avastin anti-cancer drug will show any benefit in preventing the recurrence of colorectal cancer following surgery, reports PharmaWire via the Financial Times.    Avastin is one of Genentech's most valuable products, and currently rakes in sales...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 21 Aug 2008 15:28:40 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/avastin.html"><![CDATA[Avastin]]></category>
		<category domain="http://resources.bnet.com/topic/c-08.html"><![CDATA[C-08]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
</channel>
</rss>
